Form 10-Q Protalix BioTherapeutics For: Mar 31
http://archive.fast-edgar.com/20240510/A4ZQ922CZ222KTBZ2B2B2ZZ2EPAQZM2IZ262
Filed on: May 10, 2024
Form D/A Parsifal Fund, LP
http://archive.fast-edgar.com/20240510/AN22C2228222I9Z8222D2ZOETJMKS222Z262
Filed on: May 10, 2024
Form 8-K Douglas Elliman Inc. For: May 09
0001878897false00018788972024-05-092024-05-09UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPursuant to Section 13 or 15(d) of theSecurities Exchange Act of 1934Date of Report (Date of earliest event reported): May 9, 2024 DOUGLAS ELLIMAN INC.(Exact Name of Registrant as Specified in Its Charter)Delaware(State or Other Jurisdiction of Incorporation)001-41054 87-2176850(Commission File Number) (I.R.S. Employer Identification... (continue reading...)
Form 8-K Akero Therapeutics, Inc. For: May 10
false 0001744659 0001744659 2024-05-10 2024-05-10
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 10, 2024
Akero Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-38944 81-5266573
(State or other... (continue reading...)
Form 8-K SANUWAVE Health, Inc. For: May 10
false000141766300014176632024-05-102024-05-10
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
May 10, 2024
... (continue reading...)
More SEC Filings
View Older Stories-
Form SD BECTON DICKINSON & CO
-
Form D/A Parsifal Master Fund
-
Form 8-K Sylvamo Corp For: May 10
-
Form 8-K Inspired Entertainment, For: May 10
-
Form 8-K Workhorse Group Inc. For: May 10
-
Form 10-Q Star Holdings For: Mar 31
-
Form 13F-HR Banco Santander, S.A. For: Mar 31
-
Form 6-K Crescent Point Energy For: May 10
-
Form 10-Q Luminar Technologies, For: Mar 31
-
Form 10-Q Instil Bio, Inc. For: Mar 31
-
Form 8-K Aeluma, Inc. For: May 10
-
Form 10-Q ANI PHARMACEUTICALS INC For: Mar 31
-
Form 8-K Mondee Holdings, Inc. For: May 10
-
Form D CR-0318 Fund II, a serie
-
Form 13F-NT Grupo Empresarial Santan For: Mar 31
-
Form D/A Dark Forest Global Equit
-
Form 13F-HR Intermede Investment For: Mar 31
-
Form 8-K Humacyte, Inc. For: May 10
-
Form 8-K i3 Verticals, Inc. For: May 10
-
Form 8-K PROKIDNEY CORP. For: May 10
-
Form 8-K TruBridge, Inc. For: May 10
-
Form 424B3 Goodness Growth Holdings
-
Form 10-Q ENBRIDGE INC For: Mar 31
-
Form 6-K Crescent Point Energy For: Mar 31
-
Form 10-Q DigitalOcean Holdings, For: Mar 31
-
Form 424B3 Goodness Growth Holdings
-
Form 8-K Ubiquiti Inc. For: May 10
-
Form D/A Dark Forest Global Equit
-
Form 8-K AMC Networks Inc. For: May 10
-
Form 8-K DigitalOcean Holdings, For: May 10
-
Form S-3/A Clean Energy Technologie
-
Form ARS Goodness Growth Holdings For: Dec 31
-
Form 8-K ENBRIDGE INC For: May 10
-
Form 8-K DNOW Inc. For: May 10
-
Form 13F-HR CCLA Investment Manageme For: Mar 31
-
Form 8-K KIORA PHARMACEUTICALS For: May 10
-
Form 8-K ARS Pharmaceuticals, For: May 10
-
Form DEFA14A Goodness Growth Holdings
-
Form 8-K Instil Bio, Inc. For: May 10
-
Form 6-K Telesat Corp For: May 10
-
Form 8-K DANA INC For: May 10
-
Form 10-Q KIORA PHARMACEUTICALS For: Mar 31
-
Form 424B5 Workhorse Group Inc.
-
Form 8-K EQUITY BANCSHARES INC For: May 10
-
Form 6-K Telesat Corp For: May 10
-
Form DEF 14A Goodness Growth Holdings For: Jun 21
-
Form 8-K Protalix BioTherapeutics For: May 10
-
Form S-8 KIORA PHARMACEUTICALS
-
Form 6-K INDIVIOR PLC For: May 10
-
Form 10-Q Ubiquiti Inc. For: Mar 31